Related Experiment Video
Updated: Feb 27, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation
Winnie S Wang1, Joseph D Ma1, Sandahl H Nelson1
1University of California, San Diego, San Diego, CA.
Insights
Advance care planning (ACP) and palliative care (PC) integration in hematopoietic stem-cell transplantation (HSCT) showed low outpatient code status documentation and limited PC/hospice use. Further research is needed to improve these crucial aspects of HSCT care.
Area of Science:
- Hematology
- Oncology
- Palliative Care
Background:
- Advance care planning (ACP) in hematopoietic stem-cell transplantation (HSCT) is complex due to the potential for cure alongside significant morbidity and mortality risks.
- Integrating palliative care (PC) is essential for managing complex symptoms and improving quality of life in HSCT patients.
Purpose of the Study:
- To evaluate the integration of advance care planning and palliative care for patients undergoing hematopoietic stem-cell transplantation.
- To assess the documentation of code status, advance directives, and utilization of PC and hospice services in HSCT patients.
Main Methods:
- Retrospective analysis of electronic medical records for HSCT patients (January 2011-December 2015).
- Exclusion criteria included multiple transplants and age under 18.
- Primary objective: setting and clinician specialty for initial/final code status documentation. Secondary objectives: advance directive/Physician Orders for Life-Sustaining Treatment completion, PC consultation, hospice enrollment, and place of death.
Main Results:
- The study included 602 HSCT patients (39% allogeneic, 61% autologous).
- Code status documentation was high (99.2% initially full code), but outpatient documentation was low (3% initial, 24% final).
- Palliative care consultation occurred in 19% of patients, primarily in-hospital. Advance directive completion was associated with allogeneic transplant type and age. Hospice enrollment was low (15%), with most deaths (85%) occurring in-hospital.
Conclusions:
- This single-center study highlights low outpatient code status documentation and underutilization of palliative care and hospice services among HSCT patients.
- There is a need to improve the integration of advance care planning and palliative care throughout the HSCT journey, particularly in outpatient settings.
Purpose:
Advance care planning (ACP) in hematopoietic stem-cell transplantation (HSCT) is challenging, given the potential for cure despite increased morbidity and mortality risk.The aim of this study was to evaluate ACP and palliative care (PC) integration for patients who underwent HSCT.
Methods:
A retrospective analysis was conducted and data were extracted from electronic medical records of patients who underwent HSCT between January 2011 and December 2015. Patients who received more than one transplant and who were younger than 18 years of age were excluded. The primary objective was to determine the setting and specialty of the clinician who documented the initial and final code status. Secondary objectives included evaluation of advance directive and/or completion of the Physician Orders for Life-Sustaining Treatment form, PC consultation, hospice enrollment, and location of death.
Results:
The study sample comprised 39% (n = 235) allogeneic and 61% (n = 367) autologous HSCTs. All patients except one (n = 601) had code status documentation, and 99.2% (n = 596) were initially documented as full code. Initial and final code status documentation in the outpatient setting was 3% (n = 17) and 24% (n = 143), respectively. PC consultation occurred for 19% (n = 114) of HSCT patients, with 83% (n = 95) occurring in the hospital. Allogeneic transplant type and age were significantly associated with greater rates of advance directive and/or Physician Orders for Life-Sustaining Treatment completion. Most patients (85%, n = 99) died in the hospital, and few were enrolled in hospice (15%, n = 17).
Conclusion:
To our knowledge, this is the largest single-center study of ACP and PC integration for patients who underwent HSCT. Code status documentation in the outpatient setting was low, as well as utilization of PC and hospice services.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Continuing Care
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Planning Nursing Care I
Multipotency of Hematopoietic Stem Cells

